3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
44
Neoplasms
15
Pain
12
Hot Flashes
10
Peripheral Nervous System Diseases
8
Prostatic Neoplasms
7
Lung Neoplasms
7
Sleep Initiation and Maintenance Disorders
6
Multiple Myeloma
6
Fatigue
6
Stomach Neoplasms
4
Polycystic Ovary Syndrome
4
Depression
4
Anxiety Disorders
4
Agnosia
4
Xerostomia
3
Nasopharyngeal Neoplasms
3
Lymphoma
3
Lymphedema
3
Head and Neck Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Cancer Pain
3
Vomiting
2
Squamous Cell Carcinoma of Head and Neck
2
Signs and Symptoms
2
Pancreatic Neoplasms
2
Oropharyngeal Neoplasms
2
Neurotoxicity Syndromes
2
Neoplasm Metastasis
2
Interventions
Dexamethasone
2
phenazine
1
esmolol
1
Surveys and Questionnaires
1
Sufentanil
1
Promethazine
1
Postoperative Care
1
Ondansetron
1
Fentanyl
1
Famotidine
1
Electroacupuncture
1
Electric Stimulation Therapy
1
Electric Stimulation
1
Diphenhydramine
1
Dexmedetomidine
1
Calcium Dobesilate
1
Antiemetics
1
Anesthesia, General
1
Anesthesia
1
Adrenergic beta-Antagonists
1
Acupuncture Therapy
1
((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Postoperative Nausea and Vomiting
×
Acupuncture Therapy
×
Clear all
NCT02509143
2024-08-12
AcuPONV
Pusan National University Yangsan Hospital
Phase NA
Completed
60 enrolled